GB9216082D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Univ Nottingham |
Lymphatic delivery composition
|
US5346702A
(en)
*
|
1992-12-04 |
1994-09-13 |
Sterling Winthrop Inc. |
Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
|
US5298262A
(en)
*
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
US5429824A
(en)
*
|
1992-12-15 |
1995-07-04 |
Eastman Kodak Company |
Use of tyloxapole as a nanoparticle stabilizer and dispersant
|
US5352459A
(en)
*
|
1992-12-16 |
1994-10-04 |
Sterling Winthrop Inc. |
Use of purified surface modifiers to prevent particle aggregation during sterilization
|
US5326552A
(en)
*
|
1992-12-17 |
1994-07-05 |
Sterling Winthrop Inc. |
Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants
|
US5628981A
(en)
*
|
1994-12-30 |
1997-05-13 |
Nano Systems L.L.C. |
Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents
|
ATE274341T1
(de)
*
|
1995-02-24 |
2004-09-15 |
Elan Pharma Int Ltd |
Nanopartikel-dispersionen enthaltende aerosole
|
CA2234957C
(en)
|
1995-10-17 |
2006-12-19 |
Inge B. Henriksen |
Insoluble drug delivery
|
US20050267302A1
(en)
*
|
1995-12-11 |
2005-12-01 |
G.D. Searle & Co. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
WO1998007414A1
(en)
*
|
1996-08-22 |
1998-02-26 |
Research Triangle Pharmaceuticals Ltd. |
Compositions comprising microparticles of water-insoluble substances and method for preparing same
|
AU743917B2
(en)
*
|
1996-08-22 |
2002-02-07 |
Rtp Pharma Corporation |
Compositions comprising microparticles of water-insoluble substances
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
JP4709378B2
(ja)
|
1998-03-30 |
2011-06-22 |
オバン・エナジー・リミテッド |
水不溶性物質のマイクロ粒子を製造するための組成物及び方法
|
US6337092B1
(en)
|
1998-03-30 |
2002-01-08 |
Rtp Pharma Inc. |
Composition and method of preparing microparticles of water-insoluble substances
|
AU764001B2
(en)
|
1998-05-29 |
2003-08-07 |
Skyepharma Canada Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
US20070160675A1
(en)
*
|
1998-11-02 |
2007-07-12 |
Elan Corporation, Plc |
Nanoparticulate and controlled release compositions comprising a cephalosporin
|
IL142896A0
(en)
|
1998-11-02 |
2002-04-21 |
Elan Corp Plc |
Multiparticulate modified release composition
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
US6969529B2
(en)
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
CA2349203C
(en)
|
1998-11-20 |
2013-05-21 |
Rtp Pharma Inc. |
Dispersible phospholipid stabilized microparticles
|
US6270806B1
(en)
|
1999-03-03 |
2001-08-07 |
Elan Pharma International Limited |
Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
|
US6267989B1
(en)
|
1999-03-08 |
2001-07-31 |
Klan Pharma International Ltd. |
Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
|
US7919119B2
(en)
*
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US20030228288A1
(en)
|
1999-10-15 |
2003-12-11 |
Scarborough Nelson L. |
Volume maintaining osteoinductive/osteoconductive compositions
|
CN100413881C
(zh)
*
|
1999-12-08 |
2008-08-27 |
法马西亚公司 |
依匹乐酮晶形
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
US20030083493A1
(en)
*
|
1999-12-08 |
2003-05-01 |
Barton Kathleen P. |
Eplerenone drug substance having high phase purity
|
JP2003523954A
(ja)
*
|
1999-12-08 |
2003-08-12 |
ファルマシア コーポレイション |
治療効果が迅速に開始されるシクロオキシゲナーゼ−2阻害剤組成物
|
EP1276465B1
(en)
|
2000-04-20 |
2014-03-12 |
Jagotec AG |
Improved water-insoluble drug particle process
|
AU2001259671B2
(en)
|
2000-05-10 |
2004-06-24 |
Rtp Pharma Inc. |
Media milling
|
MY120279A
(en)
*
|
2000-05-26 |
2005-09-30 |
Pharmacia Corp |
Use of a celecoxib composition for fast pain relief
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
US9387094B2
(en)
|
2000-07-19 |
2016-07-12 |
Warsaw Orthopedic, Inc. |
Osteoimplant and method of making same
|
ATE424811T1
(de)
|
2000-08-31 |
2009-03-15 |
Jagotec Ag |
Gemahlene partikel
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
EP1341521B1
(en)
*
|
2000-11-20 |
2009-01-07 |
Elan Pharma International Limited |
Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
EP1339390A2
(en)
*
|
2000-12-06 |
2003-09-03 |
Pharmacia Corporation |
Laboratory scale milling process
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
JP2004523552A
(ja)
*
|
2001-02-22 |
2004-08-05 |
スカイファーマ・カナダ・インコーポレーテッド |
低減した摂食−絶食効果を伴うフィブラート−スタチンの組合わせ
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
US20030087308A1
(en)
*
|
2001-06-22 |
2003-05-08 |
Elan Pharma International Limited |
Method for high through put screening using a small scale mill or microfluidics
|
US7758890B2
(en)
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
US20030073609A1
(en)
|
2001-06-29 |
2003-04-17 |
Pinkerton Thomas C. |
Enhanced pharmacokinetic profile of intradermally delivered substances
|
DE60217367T2
(de)
*
|
2001-09-19 |
2007-10-18 |
Elan Pharma International Ltd. |
Nanopartikelzusammensetzungen enthaltend insulin
|
BR0212822A
(pt)
*
|
2001-09-25 |
2005-08-30 |
Pharmacia Corp |
Formas cristalinas de n-(2-hidroxiacetil)-5-(4-piperdil)-4-(4-pirimidinil)-3-(4-clo rofenil)pirazol e composições farmacêuticas contendo as mesmas
|
JP2005504090A
(ja)
|
2001-09-26 |
2005-02-10 |
バクスター・インターナショナル・インコーポレイテッド |
分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
WO2003055469A1
(en)
*
|
2001-12-21 |
2003-07-10 |
Celator Technologies Inc. |
Improved polymer-lipid delivery vehicles
|
ATE371442T1
(de)
*
|
2001-10-12 |
2007-09-15 |
Elan Pharma Int Ltd |
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
|
GB0125061D0
(en)
*
|
2001-10-18 |
2001-12-12 |
Norton Healthcare Ltd |
Pharmaceutical composition
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
US20030152519A1
(en)
*
|
2001-11-07 |
2003-08-14 |
Reinhard Koenig |
Methods for vascular imaging using nanoparticulate contrast agents
|
US20030235619A1
(en)
*
|
2001-12-21 |
2003-12-25 |
Christine Allen |
Polymer-lipid delivery vehicles
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
AU2003210517A1
(en)
|
2002-02-04 |
2003-09-02 |
Elan Pharma International, Ltd. |
Drug nanoparticles with lysozyme surface stabiliser
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
WO2003080023A2
(en)
*
|
2002-03-20 |
2003-10-02 |
Elan Pharma International Limited |
Fast dissolving dosage forms having reduced friability
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
AU2003230885A1
(en)
|
2002-04-12 |
2003-10-27 |
Elan Pharma International Ltd. |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US20040018242A1
(en)
*
|
2002-05-06 |
2004-01-29 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
CA2488498A1
(en)
*
|
2002-06-10 |
2003-12-18 |
Elan Pharma International Limited |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
US7939170B2
(en)
*
|
2002-08-15 |
2011-05-10 |
The Rockefeller University |
Water soluble metal and semiconductor nanoparticle complexes
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
US7713551B2
(en)
*
|
2002-09-11 |
2010-05-11 |
Elan Pharma International Ltd. |
Gel stabilized nanoparticulate active agent compositions
|
JP2006501936A
(ja)
*
|
2002-10-04 |
2006-01-19 |
エラン ファーマ インターナショナル,リミティド |
固体ナノ粒子活性薬剤のガンマ線照射
|
CA2504610C
(en)
*
|
2002-11-12 |
2012-02-21 |
Elan Pharma International Ltd. |
Fast-disintegrating solid dosage forms being not friable and comprising pullulan
|
AU2003297151A1
(en)
*
|
2002-12-17 |
2004-07-22 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
DK1593091T3
(da)
|
2003-01-25 |
2013-10-28 |
Seno Medical Instr Inc |
Optoakustisk afbildning med høj kontrast ved anvendelse af ikke-sfæriske nanopartikler
|
EP1587499A1
(en)
*
|
2003-01-31 |
2005-10-26 |
Elan Pharma International Limited |
Nanoparticulate topiramate formulations
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
JP2007501683A
(ja)
*
|
2003-05-22 |
2007-02-01 |
エラン ファーマ インターナショナル リミテッド |
γ線照射によるナノ粒子活性物質分散体の滅菌法
|
DE602004018150D1
(de)
*
|
2003-08-08 |
2009-01-15 |
Elan Pharma Int Ltd |
Neue metaxalon-zusammensetzungen
|
EP1663321B1
(en)
|
2003-09-22 |
2012-08-29 |
Baxter International Inc. |
High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
|
DE10347994A1
(de)
*
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
WO2005041933A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Teva Pharmaceutical Industries, Ltd. |
Nanoparticles for drug delivery
|
CA2544627A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
EP1559419A1
(en)
*
|
2004-01-23 |
2005-08-03 |
Fournier Laboratories Ireland Limited |
Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention
|
EP1786443B1
(en)
*
|
2004-07-19 |
2018-06-06 |
Celator Pharmaceuticals, Inc. |
Particulate constructs for release of active agents
|
EP1621200A1
(en)
*
|
2004-07-26 |
2006-02-01 |
Fournier Laboratories Ireland Limited |
Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate
|
US20090155331A1
(en)
*
|
2005-11-16 |
2009-06-18 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
US7910577B2
(en)
|
2004-11-16 |
2011-03-22 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
MX2007007342A
(es)
*
|
2004-12-15 |
2007-12-11 |
Elan Pharma Int Ltd |
Formulaciones de tacrolimus nanoparticuladas.
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
BRPI0606434A2
(pt)
*
|
2005-01-06 |
2009-06-30 |
Elan Pharma Int Ltd |
formulações de candesartana nanoparticulada
|
EP2353590A1
(en)
*
|
2005-02-15 |
2011-08-10 |
Elan Pharma International Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
JP2008531721A
(ja)
*
|
2005-03-03 |
2008-08-14 |
エラン・ファルマ・インターナショナル・リミテッド |
複素環式アミド誘導体のナノ粒子状組成物
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
AU2006225117A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Elan Pharma International Limited |
Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
|
CN101198316A
(zh)
*
|
2005-03-17 |
2008-06-11 |
伊兰制药国际有限公司 |
纳米微粒双膦酸盐组合物
|
AU2006226887A1
(en)
*
|
2005-03-23 |
2006-09-28 |
Elan Pharma International Limited |
Nanoparticulate corticosteroid and antihistamine formulations
|
CA2603084A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
WO2006110809A2
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
JP2008535924A
(ja)
*
|
2005-04-12 |
2008-09-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子キナゾリン誘導体製剤
|
WO2006132752A1
(en)
*
|
2005-05-10 |
2006-12-14 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
CN101212954A
(zh)
*
|
2005-05-10 |
2008-07-02 |
伊兰制药国际有限公司 |
纳米粒氯吡格雷制剂
|
BRPI0614080A2
(pt)
*
|
2005-05-16 |
2017-07-25 |
Elan Pharma Int Ltd |
Composição e método para a preparação de uma cefalosporina nanoparticulada, para o tratamento de doença bacteriana e para a prevenção e/ou tratamento de osteoporose
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
WO2006133045A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
AU2006309295B2
(en)
*
|
2005-06-03 |
2012-04-26 |
Elan Pharma International Limited |
Nanoparticulate acetaminophen formulations
|
EA015102B1
(ru)
*
|
2005-06-03 |
2011-06-30 |
Элан Фарма Интернэшнл Лтд. |
Препараты наночастиц мезилата иматиниба
|
DE112006001606T5
(de)
|
2005-06-08 |
2009-07-09 |
Elan Pharma International Ltd., Athlone |
Nanopartikuläre und eine kontrollierte Freisetzung aufweisende Zusammensetzung, die Cefditoren umfassen
|
ATE446742T1
(de)
*
|
2005-06-09 |
2009-11-15 |
Elan Pharma Int Ltd |
Nanopartikuläre ebastinformulierungen
|
JP2008543843A
(ja)
*
|
2005-06-13 |
2008-12-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子クロピドグレル及びアスピリンの配合製剤
|
US20100221327A1
(en)
*
|
2005-06-15 |
2010-09-02 |
Elan Pharma International Limited |
Nanoparticulate azelnidipine formulations
|
DE202005009755U1
(de)
*
|
2005-06-21 |
2005-09-08 |
Cervitech, Inc. |
Halter für Zwischenwirbelprothesen
|
JP2009500356A
(ja)
*
|
2005-07-07 |
2009-01-08 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子クラリスロマイシン製剤
|
NZ565874A
(en)
*
|
2005-08-19 |
2010-11-26 |
Cryovac Inc |
Film comprising silicate platelets exfoliated from phospholipid-intercalated layered silicate
|
WO2007033239A2
(en)
*
|
2005-09-13 |
2007-03-22 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
EP1933814A2
(en)
*
|
2005-09-15 |
2008-06-25 |
Elan Pharma International Limited |
Nanoparticulate aripiprazole formulations
|
US20070072293A1
(en)
*
|
2005-09-26 |
2007-03-29 |
Manoj Kole |
Process for stabilization of bacterial cells
|
AU2006318349B2
(en)
*
|
2005-11-28 |
2010-08-19 |
Marinus Pharmaceuticals |
Ganaxolone formulations and methods for the making and use thereof
|
US20070178051A1
(en)
*
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
EP2040675A1
(en)
*
|
2006-05-30 |
2009-04-01 |
Elan Pharma International Limited |
Nanoparticulate posaconazole formulations
|
US20090074872A1
(en)
*
|
2006-06-26 |
2009-03-19 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
BRPI0713533A2
(pt)
*
|
2006-06-26 |
2012-04-17 |
Mutual Pharmaceutical Co |
formulações de agente ativo, métodos de fabricação, e métodos de uso
|
IN2014MN00380A
(cs)
|
2006-06-30 |
2015-06-19 |
Iceutica Pty Ltd |
|
JP2009543797A
(ja)
*
|
2006-07-10 |
2009-12-10 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子ソラフェニブ製剤
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
BRPI0717721A2
(pt)
|
2006-11-28 |
2013-10-29 |
Marinus Pharmaceuticals |
"partículas complexadas de drogas, composição farmacêutica, uso de uma composição farmacêutica, partículas complexadas de droga estabilizadas no tamanho, método para a preparação de partículas estabilizadas da droga, composição farmacêutica sólida, comprimido oral ingerível e composição líquida em nanopartículas estabilizadas no tamanho"
|
US8309129B2
(en)
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
WO2008135855A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8974827B2
(en)
|
2007-06-04 |
2015-03-10 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
WO2009073215A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
WO2009073216A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
WO2009117401A2
(en)
*
|
2008-03-21 |
2009-09-24 |
Elan Pharama International Limited |
Compositions for site-specific delivery of imatinib and methods of use
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
GB2460915B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
|
EP2368989A4
(en)
|
2008-11-26 |
2012-09-26 |
Chugai Pharmaceutical Co Ltd |
OLOGORIBONUCLEOTIDE OR PEPTIDE NUCLEIC ACID CAPABLE OF INHIBITING HEPATITIS C VIRUS ACTIVITY
|
KR101727333B1
(ko)
*
|
2008-11-26 |
2017-04-14 |
추가이 세이야쿠 가부시키가이샤 |
베시클 제제
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
WO2010096558A1
(en)
|
2009-02-18 |
2010-08-26 |
Eyeon Particle Sciences Llc |
Bi-functional co-polymer use for ophthalmic and other topical and local applications
|
US20120065221A1
(en)
|
2009-02-26 |
2012-03-15 |
Theraquest Biosciences, Inc. |
Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
|
US7828996B1
(en)
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
DK2421513T3
(en)
|
2009-04-24 |
2018-03-26 |
Iceutica Pty Ltd |
UNKNOWN FORMULATION WITH INDOMETHACIN
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
EP2435027B1
(en)
|
2009-05-27 |
2016-10-05 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate meloxicam compositions
|
PL2952191T3
(pl)
|
2009-06-12 |
2019-02-28 |
Sunovion Pharmaceuticals Inc. |
Apomorfina w postaci do podawania podjęzykowego
|
US20120128740A1
(en)
|
2009-06-19 |
2012-05-24 |
Filipcsei Genoveva |
Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
EP2560624B1
(en)
|
2010-04-23 |
2018-07-04 |
KemPharm, Inc. |
Therapeutic formulation for reduced drug side effects
|
US9012511B2
(en)
|
2010-05-19 |
2015-04-21 |
Alkermes Pharma Ireland Limited |
Nanoparticulate cinacalcet compositions
|
HUP1000299A2
(hu)
|
2010-06-08 |
2012-02-28 |
Nanoform Cardiovascular Therapeutics Ltd |
Nanostrukturált Atorvastatint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás elõállításukra
|
WO2012083269A1
(en)
|
2010-12-16 |
2012-06-21 |
Cynapsus Therapeutics, Inc. |
Sublingual films
|
DK2748146T3
(en)
|
2011-07-22 |
2017-05-22 |
Chemocentryx Inc |
CRYSTALLINE FORM OF THE SODIUM SALT OF 4-TERT-BUTYL-N- [4-CHLOR-2- (1-OXY-PYRIDINE-4-CARBONYL) -PHENYL] -BENZEN SULPHONAMIDE
|
WO2013016156A1
(en)
|
2011-07-22 |
2013-01-31 |
Glaxo Group Limited |
Polymorphic forms of the sodium salt of 4-tert- butyl -n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
|
MY172885A
(en)
|
2011-09-01 |
2019-12-13 |
Glaxo Group Ltd |
Novel crystal form
|
EP2768481A4
(en)
|
2011-10-21 |
2015-07-08 |
Subhash Desai |
COMPOSITIONS TO REDUCE SIDE EFFECTS
|
US9251937B2
(en)
*
|
2012-06-29 |
2016-02-02 |
General Electric Company |
Heat stable nanoparticle preparations and associated methods thereof
|
WO2014178873A1
(en)
*
|
2013-05-02 |
2014-11-06 |
Empire Technology Development Llc |
Composition of hydrophilic painted surface
|
US11257630B2
(en)
|
2013-07-06 |
2022-02-22 |
Blue Horizons Innovations, Llc |
Primary nanoparticle fabrication
|
HU231309B1
(hu)
|
2014-02-25 |
2022-11-28 |
Darholding Kft. |
Nanostrukturált Indomethacint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás előállításukra
|
US9468626B2
(en)
|
2014-03-13 |
2016-10-18 |
Chiesi Farmaceutici S.P.A. |
Melatonin-based formulations for parenteral administration
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
CA2952567A1
(en)
|
2014-06-25 |
2015-12-30 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
|
EP3508196B1
(en)
|
2014-08-18 |
2021-07-14 |
Alkermes Pharma Ireland Limited |
Aripiprazole prodrug compositions
|
US10016415B2
(en)
|
2014-08-18 |
2018-07-10 |
Alkermes Pharma Ireland Limited |
Aripiprazole prodrug compositions
|
CN107148418A
(zh)
|
2014-09-08 |
2017-09-08 |
葛兰素史密斯克莱知识产权发展有限公司 |
2‑(4‑(4‑乙氧基‑6‑氧代‑1,6‑二氢吡啶‑3‑基)‑2‑氟苯基)‑n‑(5‑(1,1,1‑三氟‑2‑甲基丙‑2‑基)异噁唑‑3‑基)乙酰胺的晶型
|
US10166197B2
(en)
|
2015-02-13 |
2019-01-01 |
St. John's University |
Sugar ester nanoparticle stabilizers
|
CA3019769C
(en)
|
2015-04-21 |
2021-10-12 |
Sunovion Pharmaceuticals Inc. |
Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
|
WO2016178876A2
(en)
|
2015-05-01 |
2016-11-10 |
Cocrystal Pharma, Inc. |
Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
|
CA3001722A1
(en)
|
2015-10-16 |
2017-04-20 |
Marinus Pharmaceuticals, Inc. |
Injectable neurosteroid formulations containing nanoparticles
|
WO2017143017A1
(en)
|
2016-02-17 |
2017-08-24 |
Alkermes Pharma Ireland Limited |
Compositions of multiple aripiprazole prodrugs
|
MX2019001669A
(es)
|
2016-08-11 |
2019-09-27 |
Ovid Therapeutics Inc |
Metodos y composiciones para el tratamiento de trastornos epilepticos.
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
US11266662B2
(en)
|
2018-12-07 |
2022-03-08 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of postpartum depression
|
US11901133B2
(en)
|
2019-03-20 |
2024-02-13 |
Blue Horizons Innovations, Llc |
Dense energy storage element with multilayer electrodes
|
US20220332656A1
(en)
|
2019-03-20 |
2022-10-20 |
Blue Horizons Innovations,LLC |
Nano particle agglomerate reduction to primary particle
|
WO2021026124A1
(en)
|
2019-08-05 |
2021-02-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in treatment of status epilepticus
|
WO2021072325A1
(en)
|
2019-10-11 |
2021-04-15 |
Corbus Pharmaceuticals, Inc. |
Compositions of ajulemic acid and uses thereof
|
JP2023503928A
(ja)
|
2019-12-06 |
2023-02-01 |
マリナス ファーマシューティカルズ, インコーポレイテッド |
結節性硬化症の治療での使用のためのガナキソロン
|
WO2021188162A1
(en)
*
|
2020-03-19 |
2021-09-23 |
Frank David L |
Primary nanoparticle fabrication
|
US11980636B2
(en)
|
2020-11-18 |
2024-05-14 |
Jazz Pharmaceuticals Ireland Limited |
Treatment of hematological disorders
|